Apollomics Net Income From Continuing Ops from 2010 to 2025

APLMW Stock   0.03  0.00  0.00%   
Apollomics Warrant Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -163.1 M in 2025. During the period from 2010 to 2025, Apollomics Warrant Net Loss regression line of quarterly data had mean square error of 1429.5 T and geometric mean of  94,589,269. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-155.3 M
Current Value
-163.1 M
Quarterly Volatility
51 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Apollomics Warrant financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apollomics Warrant's main balance sheet or income statement drivers, such as Tax Provision of 12.1 K, Net Interest Income of 728.1 K or Interest Income of 544.8 K, as well as many indicators such as Price To Sales Ratio of 9.6 K, Dividend Yield of 0.0 or PTB Ratio of 165. Apollomics financial statements analysis is a perfect complement when working with Apollomics Warrant Valuation or Volatility modules.
  
Check out the analysis of Apollomics Warrant Correlation against competitors.
For more information on how to buy Apollomics Stock please use our How to Invest in Apollomics Warrant guide.

Latest Apollomics Warrant's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Apollomics Warrant over the last few years. It is Apollomics Warrant's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apollomics Warrant's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Apollomics Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(103,104,865)
Geometric Mean94,589,269
Coefficient Of Variation(49.45)
Mean Deviation39,930,173
Median(74,820,000)
Standard Deviation50,984,348
Sample Variance2599.4T
Range166M
R-Value(0.70)
Mean Square Error1429.5T
R-Squared0.49
Significance0
Slope(7,471,235)
Total Sum of Squares38991.1T

Apollomics Net Income From Continuing Ops History

2025-163.1 M
2024-155.3 M
2023-172.6 M
2022-240.8 M
2021-94.8 M

About Apollomics Warrant Financial Statements

Apollomics Warrant investors use historical fundamental indicators, such as Apollomics Warrant's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apollomics Warrant. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-155.3 M-163.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apollomics Stock Analysis

When running Apollomics Warrant's price analysis, check to measure Apollomics Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apollomics Warrant is operating at the current time. Most of Apollomics Warrant's value examination focuses on studying past and present price action to predict the probability of Apollomics Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apollomics Warrant's price. Additionally, you may evaluate how the addition of Apollomics Warrant to your portfolios can decrease your overall portfolio volatility.